Search the site.

SCAN 2025 – NET patient survey (New Zealand)

The New Zealand reading of the global SCAN 2025 survey of neuroendocrine cancer patients and clinicians – how our care compares with the world.

SCAN 2025: New Zealand leads on access, but patients still wait

New Zealanders with NETs rarely pay for treatment and have world-leading access to PRRT – but 59% report delays, and only 37% have heard of clinical trials. The SCAN 2025 findings, in full.

Types of Neuroendocrine Tumours

Neuroendocrine Tumours (NETs) is an umbrella name for a number of different types of tumours, which can arise in different areas of the body. It can be…

WINZ Financial Support

Work and Income’s Special Needs Grant can help cancer patients cover essential or emergency costs they can’t afford.

Understanding Neuroendocrine

Neuroendocrine tumours (NETs) is the umbrella term for a group of unusual, often slow-growing cancers.

Patient Guide

This booklet has been developed to provide information about neuroendocrine tumours (NETs) for patients and their families.

Grades of Neuroendocrine (NET) Cancers

What G1, G2 and G3 mean for a neuroendocrine cancer diagnosis – plain-language explanation of grade, Ki-67, and how they shape treatment options.

Treatments for NETs

Treatments for neuroendocrine cancers vary from person to person and may be one or more of the options listed below.